4.2 Review

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022

Journal

BREAST CARE
Volume 17, Issue 4, Pages 403-420

Publisher

KARGER
DOI: 10.1159/000524879

Keywords

Early breast cancer; Postneoadjuvant therapy; Breast surgery; Reconstruction; Radiotherapy; Communication

Ask authors/readers for more resources

This article presents the updated treatment recommendations of the AGO Task Force on Diagnosis and Treatment of Breast Cancer, with a focus on early breast cancer. (C) 2022 S. Karger AG, Basel
Introduction: The AGO (Arbeitsgemeinschaft Gynakologische Onkologie, German Gynecological Oncology Group) Task Force on Diagnosis and Treatment of Breast Cancer as an interdisciplinary team consists of specialists from gynecological oncology, pathology, diagnostic radiology, medical oncology, and radiation oncology with a special focus on breast cancer. Methods: The updated evidence-based treatment recommendation 2022 for early breast cancer (EBC) and metastatic breast cancer of the AGO Task Force has been released. Results and Conclusion: This paper captures the update of EBC. (C) 2022 S. Karger AG, Basel

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available